Painful peripheral neuropathy and its nonsurgical treatment

Muscle and Nerve

Volumn 30, Issue 1, 2004, Pages 3-19

  Wolfe, Gil I ^a   Trivedi, Jaya R ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Anticonvulsants; Antidepressants; Neuropathic pain; Peripheral neuropathy; Treatment

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTACID AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CENTRAL DEPRESSANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIMETIDINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; FLUPHENAZINE; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; MAPROTILINE; MEXILETINE; MIANSERIN; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PHENYTOIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE;

AGRANULOCYTOSIS; ANALGESIA; APLASTIC ANEMIA; ASTHENIA; ATAXIA; BURNING SENSATION; CLINICAL TRIAL; CONFUSION; CONSTIPATION; COUGHING; DIARRHEA; DIPLOPIA; DISEASE EXACERBATION; DIZZINESS; DROWSINESS; DRUG DEPENDENCE; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; FATIGUE; GAIT DISORDER; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPONATREMIA; IMPOTENCE; INFECTION; INSOMNIA; LEUKOPENIA; LIBIDO DISORDER; LIVER DYSFUNCTION; LIVER FUNCTION; MONOTHERAPY; NAUSEA; NERVOUSNESS; NEUROPATHIC PAIN; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; POLYPHARMACY; PRIORITY JOURNAL; RASH; REVIEW; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SKIN IRRITATION; SOMNOLENCE; STEVENS JOHNSON SYNDROME; SWEATING; SYMPTOMATOLOGY; THROMBOCYTOPENIA; TREMOR; URINE RETENTION; URTICARIA; VOMITING; WEIGHT GAIN; XEROSTOMIA;

ANALGESICS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; HUMANS; NEURALGIA; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 3042815542     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20057     Document Type: Review

References (104)

1. Ascher JA, Cole JO, Colin JN, Feighner JP, Ferris RM, Fibiger HC, Golden RN, Martin P, Potter WZ, Richelson E. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 1995;56:395-401.
2. Backonja M. Use of anticonvulsants for treatment of neuropathic pain. Neurology 2002;59:S14-S17.
3. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 1998;280:1831-1836.
4. Backonja M, Glanzman RL. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther 2003;25:81-104.
5. Bennett G. The role of the sympathetic nervous system in painful peripheral neuropathy. Pain 1991;45:221-223.
6. Besson JM. The neurobiology of pain. Lancet 1999;353:1610-1615.
7. Biesbroeck R, Bril V, Hollander P, Kabadi U, Schwartz S, Singh SP, Ward WK, Bernstein JE. A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy. Adv Ther 1995;12:111-120.
8. Calissi PT, Jaber LA. Peripheral diabetic neuropathy: current concepts of treatment. Ann Pharmacother 1995;29:769-777.
9. Capsaicin Study Group. Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care 1991;15:159-165.
10. Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin: a multicenter, double-blind, vehicle-controlled study. Arch Intern Med 1991;151:2225-2229.
11. Carrazana E, Mikoshiba I. Rationale and evidence for the use of oxcarbazepine in neuropathic pain. J Pain Symptom Manage 2003;25:S31-S35.
12. Carter GT, Galer BS. Advances in the management of neuropathic pain. Phys Med Rehabil Clin N Am 2001;12:447-459.
13. Chad DA, Aronin N, Lundstrom R, McKeon P, Ross D, Molitch M, Schipper HM, Stall G, Dyess E, Tarsy D. Does capsaicin relieve the pain of diabetic neuropathy? Pain 1990;42:387-388.
14. Chadda VS, Mathur MS. Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathic pain. J Assoc Physicians India 1978;26:403-406.
15. Chong MS, Bajwa ZH. Diagnosis and treatment of neuropathic pain. J Pain Symptom Manage 2003;25:S4-S11.
16. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. Br Med J 1995;310:452-454.
17. Dallocchio C, Buffa C, Mazzarello P, Chiroli S. Gabapentin vs. amitriptyline in painful diabetic neuropathic pain: an open-label pilot study. J Pain Symptom Manage 2000;20:280-285.
18. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983;17:197-210.
19. Dejgård A, Petersen P, Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 1988;1:9-11.
20. Devor M. The pathophysiology of damaged peripheral nerves. In: Wall PD, Melzack R, editors. Textbook of pain. Edinburgh: Churchill Livingstone; 1994. p 79-100.
21. Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 2001;57:505-509.
22. Ertas M, Sagduyu A, Arac N, Uludag B, Ertekin C. Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain 1998;75:257-259.
23. Fitzgerald M. Capsaicin and sensory neurons: a review. Pain 1983;15:109-130.
24. Galer BS. Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology 1995;45(Suppl 9):S17-S25.
25. Galer BS. Painful polyneuropathy. Neurol Clin 1998;16:791-811.
26. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000;47:123-128.
27. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997;48:332-338.
28. Gilron I, Bailey J, Weaver DF, Houlden RL. Patients' attitudes and prior treatments in neuropathic pain: a pilot study. Pain Res Manage 2002;7:199-203.
29. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled study. Neurology 2003;60:927-934.
30. Gomez-Perez FJ, Rull JA, Dies H, Rodriquez-Rivera JG, Gonzalez-Barranco J, Lozano-Castañeda O. Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study. Pain 1985;23:395-400.
31. Gorson K, Schott C, Herman R, Ropper AH, Rand WM. Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial. J Neurol Neurosurg Psychiatry 1999;66:251-252.
32. Gracely RH, Lynch SA, Bennett GJ. Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain 1992;51:175-194.
33. Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, Donofrio P, Cornblath D, Sachdeo R, Siu CO, Kamin M. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998;50:1842-1846.
34. Harati Y, Gooch C, Swenson M, Edelman SV, Greene D, Raskin P, Donofrio P, Cornblath D, Olson WH, Kamin M. Maintenance of long-term effectiveness of tramadol in treatment of the pain in diabetic neuropathy. J Diabetes Complic 2000;14:65-70.
35. Holland NR. Idiopathic painful sensory neuropathy. J Clin Neuromusc Dis 2001;2:211-220.
36. Holland NR, Crawford TO, Hauer P, Cornblath D, Griffin JW, McArthur JC. Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 1998;44:47-59.
37. Holliday SM, Benfield P. Venlafaxine: a review of its pharmacology and therapeutic potential in depression. Drugs 1995;49:280-294.
38. Jensen TS. Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur J Pain 2002;6:61-68.
39. Kemper CA, Kent G, Burton S, Deresinski SC. Mexiletine for HIV-infected patients with painful peripheral neuropathy: a double-blind, placebo-controlled, crossover treatment trial. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:367-372.
40. Kieburtz K, Simpson D, Yiannoutsos C, Max MB, Hall CD, Ellis RJ, Marra CM, McKendall R, Singer E, Dal Pan GJ, Clifford DB, Tucker T, Cohen B. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. Neurology 1998;51:1682-1688.
41. Kochar DK, Jain N, Agarwal RP, Srivastava T, Agarwal P, Gupta S. Sodium valproate in the management of painful neuropathy in type 2 diabetes - a randomized placebo controlled study. Acta Neurol Scand 2002;106:248-252.
42. Kunz NR, Goli V, Entsuah AR. Venlafaxine extended release in the treatment of pain associated with diabetic neuropathy. Neurology 2000;54(Suppl 3):A441.
43. Kuzniecky R, Ho S, Pan J, Martin R, Gilliam F, Faught E, Hetherington H. Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology 2002;58:368-372.
44. Kvinesdal B, Molin J, Froland A, Gram LF. Imipramine treatment of painful diabetic neuropathy. JAMA 1984;251:1727-1730.
45. Lacomis D. Small-fiber neuropathy. Muscle Nerve 2002;26:173-188.
46. Leach MJ, Marden CM, Miller AA. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia 1986;27:490-497.
47. Low PA, Opfer-Gehrking TL, Dyck PJ, Litchy WJ, O'Brien PC. Double-blind placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy. Pain 1995;62:163-168.
48. Luciano CA, Russell JW, Banarjee TK, Quirk JM, Scott LJC, Dambrosia JM, Barton NW, Schiffman R. Physiological characterization of neuropathy in Fabry disease. Muscle Nerve 2002;26:622-629.
49. Max MB, Culnane M, Schafer SC, Gracely RH, Walther DJ, Smoller B, Dubner R. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987;37:589-596.
50. Max MB, Kishore-Kumar R, Schafer SC, Meister B, Gracely RH, Smoller B, Dubner R. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain 1991;45:3-9.
51. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-1256.
52. May TW, Korn-Merker E, Rambeck B. Clinical pharmacokinetics of oxcarbazepine. Clin Pharmacokinet 2003;42:1023-1042.
53. McCleane G. 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomized, double-blind, placebo-controlled trial. Pain 1999;83:105-107.
54. McCleane GJ. Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study. Anesth Analg 1999;89:985-988.
55. McQuay HJ, Tramèr M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217-227.
56. Melzack R. The short-form McGill Pain Questionnaire. Pain 1987;30:191-197.
57. Mendell JR, Sahenk Z. Painful sensory neuropathy. N Engl J Med 2003;348:1243-1255.
58. Merskey H, Bogduk N. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms, 2nd edition. Seattle: IASP Press; 1994.
59. Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999;159:1931-1937.
60. Nelson KA, Park KM, Robinovitz E, Tsigos C, Max MB. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997;48:1212-1218.
61. Nishiyama K, Sakuta M. Mexiletine for painful alcoholic neuropathy. Intern Med 1995;34:577-579.
62. Noe CE. Oral medication for chronic pain: a summary of positive randomized controlled clinical trials of oral agents used to treat chronic pain. Dallas Med J 2000;86:162-163.
63. Nolano M, Simone DA, Wendelschafer-Crabb G, Johnson T, Hazen E, Kennedy WR. Topical capsaicin in humans: parallel loss of epidermal fibers and pain sensation. Pain 1999;81:135-145.
64. Ochoa J, Torebjork HE, Culp WJ, Schady W. Abnormal spontaneous activity in single sensory nerve fibres in humans. Muscle Nerve 1982;5:S74-S77.
65. Oskarsson P, Ljunggren J-G, Lins P-E, Mexiletine Study Group. Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. Diabetes Care 1997;20:1594-1597.
66. Paice JA, Ferrans CE, Lashley FR, Shott S, Vizgirda V, Pitrak D. Topical capsaicin in the management of HIV-associated peripheral neuropathy. J Pain Symptom Manage 2000;19:45-52.
67. Pandey CK, Bose N, Garg G, Singh N, Baronia A, Agarwal A, Singh PK, Singh U. Gabapentin for the treatment of pain in Guillain-Barré syndrome: a double-blinded, placebo-controlled, crossover study. Anesth Analg 2002;95:1719-1723.
68. Pellock JM. Tricyclic anticonvulsants: safety and adverse effects. Epilepsy Behav 2002;3:S14-S17.
69. Periquet MI, Novak V, Collins MP, Nagaraja HN, Erdem S, Nash SM, Freimer ML, Sahenk Z, Kissel JT, Mendell JR. Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology 2000;53:1641-1647.
70. Petroff OAC, Rothman DL, Behar KL, Lamoureux D, Mattson RH. The effect of gabapentin on brain gamm-aminobutyric acid in patients with epilepsy. Ann Neurol 1996;39:95-99.
71. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an "atypical" opioid analgesic. J Pharmacol Exp Ther 1992;260:275-285.
72. Richter W, Barth H, Flohe L, Giertz H. Clinical investigation on the development of dependence during oral therapy with tramadol. Arzniem-Forsch/Drug Res 1985;35:1742-1744.
73. Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003;348:1223-1232.
74. Rull JA, Quibrera R, González-Millán H, Castañeda OL. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial. Diabetologia 1969;5:215-218.
75. Sang CN, Booher S, Gilron I, Parada S, Max MB. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology 2002;96:1053-1061.
76. Saudek CD, Werns S, Reidenberg MM. Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin Pharmacol Ther 1977;22:196-199.
77. Scheffler NM, Sheitel PL, Lipton MN. Treatment of painful diabetic neuropathy with capsaicin 0.075-percent. J Am Podiatr Med Assoc 1991;81:288-293.
78. Semenchuk MR, Sherman S, Davis B. Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology 2001;57:1583-1588.
79. Serpell MG, Neuropathic Pain Study Group. Gabapentin in neuropathic pain syndromes: a randomised double-blind, placebo-controlled trial. Pain 2002;99:557-566.
80. Shlay JC, Chaloner K, Max MB, Flaws B, Reichelderfer P, Wentworth D, Hillman S, Brizz B, Cohn DL. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. JAMA 1998;280:1590-1595.
81. Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromusc Dis 2001;3:53-62.
82. Simpson DM, McArthur JC, Olney R, Clifford D, So Y, Ross D, Baird BJ, Barrett P, Hammer AE. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology 2003;60:1508-1514.
83. Simpson DM, Olney R, McArthur JC, Khan A, Godbold J, Ebel-Frommer K. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neurology 2000;54:2115-2119.
84. Sindrup SH, Andersen G, Madsen C, Brøsen K, Smith T, Jensen TS. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain 1999;83:85-90.
85. Sindrup SH, Bach FW, Madsen C, Gram LF, Jensen TS. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 2003;60:1284-1289.
86. Sindrup SH, Bjerre U, Dejgaard A, Brøsen K, Aaes-Jørgensen T, Gram LF. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992;52:547-552.
87. Sindrup SH, Gram LF, Brøsen K, Eshøj O, Mogensen EF. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990;42:135-144.
88. Sindrup SH, Gram LF, Skjold T, Grodum E, Brøsen K, Beck-Neilsen H. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms: a double-blind cross-over study. Br J Clin Pharmacol 1990;30:683-691.
89. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999;83:389-400.
90. Sindrup SH, Jensen TS. Pharmacologic treatment of pain in polyneuropathy. Neurology 2000;55:915-920.
91. Sindrup SH, Tuxen C, Gram LF, Grodum E, Skjold T, Brøsen K, Beck-Nielsen H. Lack of effect of mianserin on the symptoms of diabetic neuropathy. Eur J Clin Pharmacol 1992;43:251-255.
92. Smith TE, Chong MS. Neuropathic pain. Hosp Med 2000;61:760-766.
93. Stracke H, Meyer UE, Schumacher HE, Federlin K. Mexiletine in the treatment of diabetic neuropathy. Diabetes Care 1992;15:1550-1555.
94. Tandan R, Lewis GA, Krusinski PB, Badger GB, Fries TJ. Topical capsaicin in painful diabetic neuropathy. Diabetes Care 1992;15:8-14.
95. Taylor CP, Gee NS, Su T-Z, Kocsis JD, Welty DF, Brown JP, Dooley DJ, Boden P, Singh L. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 1998;29:231-246.
96. Vrethem M, Boivie J, Arnqvist H, Holmgren H, Lindström T, Thorell L-H. A comparison of amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clin J Pain 1997;13:313-323.
97. Watson CPN, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998;50:1837-1841.
98. Wilton TD. Tegretol in the treatment of diabetic neuropathy. S Afr Med J 1974;48:869-872.
99. Wolfe GI, Baker NS, Amato AA, Jackson CE, Nations SP, Saperstein DS, Cha CH, Katz JS, Bryan WW, Barohn RJ. Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics. Arch Neurol 1999;56:540-547.
100. Wolfe GI, Barohn RJ. Cryptogenic sensory and sensorimotor polyneuropathies. Semin Neurology 1998;18:105-111.
101. Wolfe GI, Barohn RJ. Painful peripheral neuropathy. Curr Treat Options Neurol 2002;4:177-188.
102. Wolfe GI, Hotz SE, Barohn RJ. Treatment of painful peripheral neuropathy. J Clin Neuromusc Dis 2002;4:50-59.
103. Woolf CJ. Evidence for a central component of post-injury pain. Nature 1983;306:686-688.
104. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353:1959-1964.